Work

Phase I trial of Adozelesin using the treatment schedule of daily × 5 every 3 weeks

Year: 1995

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/bf00873138

Authors: Brenda J. Foster, Patricia M. LoRusso, Elizabeth Poplin, Mark Zalupski, Manuel Valdivieso, Antoinette Wozniak, Lawrence Flaherty, Dorothy A. Kasunic, Robert H. Earhart, Laurence H. Baker

Institutions: Wayne State University, Pfizer (United States)

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute

Awards: THERAPEUTICS OF NEW SOLID TUMOR ANTICANCER AGENTS, G3970719395

OpenAlex ID: W2030894725

FWCI: 0.118

Cites: 16

Cited by: 23

Related to: 10